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Psychological wellness and health-related stigma: a pilot study of an acceptance-focused cognitive behavioural
intervention for people with lung cancer
People with lung cancer experience health-related stigma that is related to poorer psychosocial and quality of
life outcomes. The present Phase 1 study applied mixed methods to test the acceptability of an acceptance-
focused cognitive behavioural intervention targeting stigma for this patient group. Fourteen lung cancer
patients completed a 6-week Psychological Wellness intervention with pre- and post-test outcome measures of
psychological and cancer-specific distress, depression, health-related stigma and quality of life. In-depth
interviews applying interpretative phenomenological analysis assessed participants’ experiences of the inter-
vention. Moderate to large improvements were observed in psychological (ηp2 = 0.182) and cancer-specific
distress (ηp2 = 0.056); depression (ηp2 = 0.621); health-related stigma (ηp2 = 0.139). In contrast, quality of life
declined (ηp2 = 0.023). The therapeutic relationship; self-management of distress; and relationship support were
highly valued aspects of the intervention. Barriers to intervention included avoidance and practical issues. The
lung cancer patients who completed the Psychological Wellness intervention reported improvements in
psychological outcomes and decreases in stigma in the face of declining quality of life with patients reporting
personal benefit from their own perspectives. A randomised controlled trial is warranted to establish the
effectiveness of this approach.
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INTRODUCTION
Internationally, lung cancer is the most common
cancer and the most common cause of cancer death
(International Agency for Research on Cancer, 2014). In
Australia lung cancer is the fourth most commonly diag-
nosed cancer and the leading cause of cancer death with
11 270 new diagnoses in 2012 and 8099 deaths in 2010;
and 5-year survival around 13% for men and 17% for
women (AIHW & AACR 2012). The most common cause
of lung cancer is smoking with 15% of lung cancer
patients presenting as non-smokers. Exposure to other
carcinogens such as occupational exposures and ionising
radiation are also implicated (Cagle et al. 2012). Lung
cancer is therefore a major public health concern.
Common physical symptoms for lung cancer include
breathlessness, coughing and fatigue and these effects
contribute to fear, depression and anxiety for patients.
Breathlessness can cause anxiety, panic attacks and fear of
impending death (Tanaka et al. 2002); and persistent
coughing can lead to sleep disturbances and exhaustion
(Vena et al. 2006). Lung cancer patients report higher levels
of psychological distress, greater unmet needs and a greater
risk of suicide compared with other patient groups. Up to
62% of lung cancer patients report significant psychologi-
cal distress (Graves et al. 2007); and for many patients this
distress does not ameliorate over time, and indeed may
worsen (Néron et al. 2007). Patients with lung cancer have
a higher risk of suicide compared with those with other
cancers such as breast, prostate and colorectal (Misono
et al. 2008). Finally, lung cancer patients report higher
unmet psychological needs than other cancer patients and
more rehabilitative problems of which psychological con-
cerns are central (Li & Girgis 2006). Therefore, evidence-
based interventions to enhance psychological adjustment
are crucial for lung cancer patients.
Problematically, people with lung cancer, more so than
patients with other cancers, feel stigmatised by their
disease and this increases distress (Chambers et al. 2012).
Stigma occurs when society labels someone as tainted on
the basis of an attribute that marks them out as different
(Goffman 1963). In lung cancer, health-related stigma
results from the association between the disease and
smoking and perception of the disease as self-inflicted; the
high mortality rates; and perceptions about the type of
death that may be experienced (Chambers et al. 2012).
Stigma is relationship and context-specific where a spe-
cific attribute is associated with a negative evaluation that
can lead to negative treatment or discrimination, stereo-
type activation and identity threat (Major & O’Brien
2005). When internalised these negative evaluations lead
to shame or guilt and fear of being discriminated against.
Responses to stigma include: increased stress and poor
coping leading to negative mental and physical health
outcomes and the amplification of psychosocial morbidity
(Heijnders & Van Der Meij 2006). A systematic review
concluded that lung cancer patients consistently report
stigma as part of their cancer experience and report social
isolation owing to the perception of lung cancer as a
disease that leads to a horrible death; feel stigmatised by
the prevailing view that all lung cancer is self-inflicted
and smoking-related; and fear that treatment may be
denied and/or is futile (Chambers et al. 2012).
Despite this, health-related stigma has not been
addressed in supportive care in lung cancer. A Cochrane
review (2011) of interventions for improving well-being
after lung cancer identified only two trials that applied
psychological therapies to reduce psychological distress
after lung cancer: neither of these targeted health-related
stigma (Rueda et al. 2011). Linn et al. (1982) trialled grief
counselling with end stage cancer hospital inpatients
(50% lung cancer; all male) and found benefits in depres-
sion after 3 months of treatment. However this study only
targeted patients approaching the end of life and attrition
was high (71% at 3 months). Porter et al. (2011) compared
14 telephone sessions to caregiver–patient dyads deliver-
ing either: caregiver assisted coping skills training or
education/support. The coping skills training applied a
cognitive behavioural approach, while the education/
support arm included disease/treatment education with
supportive discussion. No differences were found between
treatments. More recently a trial of online routine screen-
ing for distress in lung cancer patients found that patients
who received full screening for distress with personalised
triage reported fewer problems with coping and family
conflict and were more likely to access services compared
with patients who were only screened (Carlson et al.
2013). However, few patients actually accessed supportive
care services, even with triage. Hence, while we know
lung cancer patients have a high need for psychological
support and are at high risk of adverse events (e.g. clini-
cally high distress, suicide), research in this area is scant
and no interventions have been reported that targeted
health-related stigma.
In this regard, situational, individual and social factors
shape a person’s cognitive appraisals of the threat lung
cancer poses to their health and future, and their identity;
and these appraisals in turn shape the person’s psychologi-
cal outcomes (Chambers et al. 2012). Specifically, social
representations of lung cancer and associated situational
cues (e.g. being questioned repeatedly about smoking
status; viewing anti-tobacco advertisements) represent the
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context that strongly cues the patient to have negative
cognitive appraisals about their lung cancer and them-
selves. For people with lung cancer their cognitive apprais-
als about their cancer are crucial intervention targets to
ameliorate the negative effects of health-related stigma
and to reduce psychological distress. A cognitive behav-
ioural approach with a focus on lessening the effect of
negative appraisals and stigma appears relevant then to
reduce the psychological distress associated with the
experience of lung cancer. Meta-analyses have shown cog-
nitive behavioural therapy (CBT) to reduce depression and
anxiety in cancer patients with individualised interven-
tions, including tele-based approaches, more effective
than group formats (Osborn et al. 2006). Over the past
decade acceptance-based methods have been considered
for the enhancement of CBT (Segal et al. 2002). Accept-
ance strategies target not only the content of presenting
concerns; but also the function of and the relationship
to these symptoms (i.e. experiential avoidance). Tradi-
tional CBT techniques emphasise how realistic or helpful
thoughts about cancer may be, whereas acceptance strat-
egies focus on increasing a person’s ability to tolerate
unpleasant experiences including distressing thoughts
and feelings. Preliminary evidence suggests that address-
ing these ‘second-order’ processes enhances motivation
for utilising CBT strategies and supports longer-term
maintenance of CBT treatment gains (Forman et al. 2007).
Moderate to large effect sizes have been associated with
programmes integrating acceptance-based components for
the CBT treatment of anxiety and depression (Hoffman
et al. 2010). Mindfulness-based cognitive therapy (which
is an integration of CBT and a large dose of acceptance-
based methods) has been shown to be effective in decreas-
ing distress in a mixed cancer patient sample [effect size
(ES) 0.53–0.83] (Foley et al. 2010). To date, this approach
has not been tested with lung cancer patients.
Accordingly, the current study describes the develop-
ment and acceptability testing of a six session telephone
delivered Psychological Wellness intervention for lung
cancer patients that addresses health-related stigma
as a primary therapy target through the integration of
acceptance-focused strategies within a cognitive behav-
ioural framework.
METHOD
Participants and procedure
The Human Research Ethics Committee at Griffith Uni-
versity (PSY/03/13/HREC) granted ethical approval to
conduct this study. Eligibility criteria were: previous diag-
nosis of lung cancer; able to read and speak English; over
the age of 18 years; and had no current dementia or psychi-
atric illness. Recruitment was undertaken from March
2013 to September 2013. Participants were a convenience
sample recruited from local cancer support networks and
cohorts. Potential participants were mailed a cover letter,
information sheet, consent form, self-report survey, and
reply-paid envelope. From 56 potential participants, 40
agreed to take part in the study and completed baseline
assessments, which consisted of a survey and structured
telephone interview. Fifteen participants did not com-
mence the intervention after completing the baseline
assessment. Out of the 25 participants who commenced
the intervention, 14 completed the 3-month follow-up
survey. At the 3-month follow-up, all participants were
also invited to take part in a semi-structured qualitative
interview regarding the intervention. Participants who
completed the intervention were asked questions to assess
the acceptability of the intervention (n = 22 interviewed).
Participants who did not take part in the intervention were
asked why they declined to do so (n = 9 interviewed). See
Figure 1 for an overview of the recruitment, baseline and
follow-up processes.
Intervention
The Psychological Wellness intervention was based on a
tele-based CBT manualised therapy programme for cancer
patients that our group has used extensively in both prac-
tice and research that includes: psycho-education, skills in
stress reduction, problem-solving, cognitive challenging
and enhancing relationship support (Hutchison et al. 2011;
Chambers et al. 2014). First, to ensure relevance to the
illness experience of this patient group we added evidence-
based supportive care components for sleeplessness and
breathlessness for lung cancer patients (Bredin et al. 1999).
Second, an overarching approach of acceptance, in particu-
lar to address health-related stigma in lung cancer, was
woven into our CBT framework. Acceptance and interre-
lated strategies such as defusion, mindfulness and value
guided action [consistent with acceptance and commit-
ment therapy (Hayes & Wilson 2003)] were targeted to the
challenges associated with a cancer that poses high threat
to life and wellness; thoughts and feelings associated
with situational cues to stigma (e.g. anti-tobacco media;
talking about smoking with family, friends and health
professionals); and perceptions of self-blame about the
cancer. Examples of strategies included recognising and
stepping back from negative thoughts; meditation tech-
niques; acceptance of painful feelings; deliberate self-
kindness and self-soothing; identifying and orienting
towards valued activities.
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The intervention was telephone delivered in six weekly
50–55 min sessions and was delivered by telephone to
reduce barriers to access from physical illness and geo-
graphic location. Participants were provided with tip
sheets matching each weekly session; self-help materials
including Jon Kabat Zinn’s Full Catastrophe Living
(Kabat-Zinn 1990); and a meditation CD.
Measures
A structured telephone interview collected demographic
variables, smoking behaviours and cancer-related informa-
tion at baseline. A self-report survey assessing psychologi-
cal and cancer-related distress; quality of life; depression
and stigma about lung cancer was completed at baseline
and 3 months subsequently. At the 3-month follow-up all
participants were invited to take part in a semi-structured
qualitative interview about how helpful the intervention
was; what aspects of the intervention were unhelpful or
could have been improved; and for patients who did not
commence the intervention the reasons for this were
explored.
Psychological distress
The Hospital Anxiety and Depression Scale (HADS)
provided a measure of an individual’s current distress
(Zigmond & Snaith 1983). Items included ‘I have lost
Figure 1. Flowchart of recruitment, par-
ticipation, data collection and attrition.
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interest in my appearance’ and ‘I feel restless as if I have to
be on the move’. Fourteen items were responded to on a
four-point Likert scale. As in previous studies with cancer
survivors, the total HADS score was used to represent
levels of psychological distress (Smith et al. 2006). In the
present study internal consistency for total HADS scores
was high (α = 0.87).
Cancer-related distress
The Impact of Events Scale (IES) (Horowitz et al. 1979)
measured distress related to lung cancer. Participants
were asked to reflect upon how distressing each item has
been for them in relation to their cancer experience on a
four-point Likert scale from 0 (not at all), 1 (rarely), 3
(sometimes) to 5 (often). Items included ‘I thought about it
when I didn’t mean to’ and ‘I tried to remove it from my
memory’. Higher total scores indicate greater levels of
distress. Internal consistency was high (α = 0.90).
Depression
The Centre for Epidemiological Studies Depression Scale
(CESD) (Radloff 1977) assessed depression, with items
including ‘My sleep was restless’ and ‘I felt that every-
thing I did was an effort’. The CESD consisted of 20 items
rated on a scale from 0 (rarely or none of the times – less
than 1 day) to 3 (most or all of the time – 5–7 days). High
total scores are indicative of greater depressive symptoms.
Internal consistency was high (α = 0.85).
Lung cancer-related stigma
The Cataldo Lung Cancer Stigma Scale (CLCSS) (Cataldo
et al. 2011) assessed the impact of health-related stigma
on people with lung cancer. The scale contained 30 items
loading onto four subscales: stigma and shame; social iso-
lation; discrimination; and smoking. Items included ‘I feel
guilt because I have lung cancer’ and ‘I was hurt by how
people reacted to learning I have lung cancer’. Participants
rated each item on a four-point Likert scale ranging from
1 (strongly disagree) to 4 (strongly agree) with higher
scores indicating a greater level of perceived stigma. Inter-
nal consistencies for the overall measure (α = 0.94) and
subscales (α = 0.76 to 0.96) were high.
Quality of life
The Functional Assessment of Cancer Therapy – Lung
(FACT-L) (Cella et al. 1993) assessed perceived global
quality of life across five domains: physical, social/family,
emotional, functional well-being and lung cancer-specific
concerns. The FACT-L consists of 36 items rated on a
five-point Likert scale ranging from 0 (not at all) to 4 (very
much). Items included ‘I get emotional support from my
family’ and ‘I am satisfied with how I am coping with my
illness’. Higher total scores indicated greater overall well-
being. Internal consistency was high (α = 0.87).
Data analysis
Differences between participants who commenced the
intervention and those who did not take part in any ses-
sions were examined for demographic, cancer-related and
smoking-related variables via t-tests (normally distributed
continuous variables), Mann–Whitney tests (skewed con-
tinuous variables) and chi-square analyses (categorical
variables). The post-intervention CESD variable contained
three scores that were two standard deviations above the
mean, and these outliers were removed when analysing
differences in CESD scores over time. Differences were
also assessed via t-tests on baseline psychosocial variables
between participants who commenced the intervention
and those who did not.
Effect sizes were used to assess efficacy of the interven-
tion as significance tests are often uninformative in the
social sciences with small sample sizes (Schmidt 1996).
Effect sizes were estimated using partial Eta squared,
which assesses variance in outcome variables due to the
intervention. Effect sizes were assessed against Cohen’s
(Cohen 1988) criteria of ηp2 = 0.01 (small), ηp2 = 0.059
(medium) and ηp2 = 0.138 (large).
Interview data were investigated using thematic analy-
sis, based on an interpretative phenomenological frame-
work that is widely used in health psychology research
(Riessman 2008). An interpretative phenomenological
framework focuses on capturing the lived experience of
the participant (Smith & Osborn 2003). The coding
approach involved a continual reviewing process with
overarching superordinate themes being identified from
the component themes through an iterative process. In
addition to data pertaining to the semi-structured ques-
tions, the interpretative phenomenological framework
also allowed for uncovering novel and discordant themes
(Riessman 2008). Consistent with quality guidelines,
two researchers (BAM, SKC) reviewed the transcripts
independently to identify responses that described the
experience of the intervention (i.e. component themes and
overarching superordinate themes) with corresponding
representative quotes (Elliott et al. 1999). Discrepancies
were resolved via discussion with verification against the
transcript data with involvement of a third coder (JD).
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RESULTS
Baseline characteristics
On average, participants who commenced the intervention
were 65.12 (SD = 9.59) years of age; were 16.35 (SD = 2.80)
years of age when they started smoking; and for those that
were no longer smoking it was a median of 5 years since
they had quit smoking [interquartile range (IQR) = 1.04
(first quartile)–19.00 (third quartile) years]. Time since
diagnosis was a highly skewed variable and the median
time was 14.50 months [IQR = 9.25 (first quartile)–22.75
(third quartile) months]. Table 1 outlines descriptive sta-
tistics for participants who commenced the intervention.
Participants who did not commence the intervention had
lower quality of life (M = 83.86, SD = 18.64, P = 0.025) and
smoked more cigarettes per day (M = 28.33, SD = 2.89,
P = 0.029) compared with participants who started the
intervention (quality of life: M = 97.60, SD = 17.15;
smoking: M = 13.33, SD = 9.27).
Adjustment outcomes
Table 2 displays descriptive statistics and effect sizes for
pre- and post-intervention distress, depression, stigma and
quality of life. Scores for psychological distress, cancer-
related distress, depression and stigma (total score, stigma
and shame subscale, and social isolation subscale) showed
improvement over time with medium to large effect sizes.
In contrast, quality of life worsened although the effect
size was small.
Qualitative interviews
Benefits of intervention
Three superordinate themes were identified: the Thera-
peutic Relationship; Self-management of Distress; Family
Relationships.
Within the Therapeutic Relationship, participants
described the value of talking to someone who was knowl-
edgeable about the situation they were facing and who
Table 1. Descriptive statistics for participants who commenced
the intervention (n = 25)
n %
Gender
Female 22 88
Male 3 12
Current smoking status
Everyday 5 20
Some days 2 8
Do not currently smoke at all 13 52
Has never smoked 5 20
Relationship status
In a relationship 12 48
Not in a relationship 13 52
Private health insurance
Yes 12 48
No 13 52
Education
High school or below 15 60
Trade or technical college 8 32
University 2 8
Current work status
Retired 16 64
Unable to work due to illness 5 20
Employed – casual 2 8
Home duties/home carer 1 4
Unemployed/looking for work 1 4
Work capacity since diagnosis
Working less hours 11 44
Same 14 56
Income per year*
Less than $74 760 21 84
$74 760 or greater 4 16
Percentages do not always equal 100% due to missing data.
*Categories based on average income for Australian earnings
(Australian Bureau of Statistics 2014).
Table 2. Pre- and post-intervention differences in psychosocial variables for participants who commenced the intervention and completed
follow-up assessment (n = 14)
Pre-intervention Post-intervention
ESM SD M SD
HADS – total score 13.93 7.46 10.93 6.58 0.182
CESD – total score 15.80 6.12 7.90 5.04 0.621
IES – total score 27.08 15.72 23.08 14.36 0.056
CLCSS – stigma & shame 18.21 5.15 16.50 4.69 0.212
CLCSS – social isolation 15.00 6.42 13.50 4.82 0.163
CLCSS – discrimination 8.79 4.21 8.43 3.01 0.012
CLCSS – smoking 13.00 3.68 12.57 3.92 0.013
CLCSS – total score 55.00 16.16 51.00 12.23 0.139
FACT-L – total score 94.14 19.29 90.93 24.96 0.023
CESD, Center for Epidemiological Studies Depression Scale; CLCSS, Cataldo Lung Cancer Stigma Scale; FACT-L, Functional
Assessment of Cancer Therapy – Lung; HADS, Hospital Anxiety Depression Scale; IES, Impact of Events Scale. ES, effect size partial
eta-squared (small = 0.01, medium = 0.059, large = 0.138).
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was independent of their family and personal support
network. From this and within an empathic and support-
ive interaction participants felt less alone. For example:
It was good knowing you were talking to someone
who was aware of the needs of someone like myself
and understands the background to it all.
I think independent. I’ve got lots of friends and
family, but it’s just to have someone independent to
talk to . . . it’s just good to talk it through with some-
body totally independent.
I think the listening and understanding, mainly . . .
the listening and the understanding and as far as my
family is concerned it’s going to go away. Whereas the
psychologists helped. She was supportive and it’s not
gonna go away.
The sessions helped me because there was somebody
on the end of the line when you’re having a down day.
And I mean if you’re having a down day you can ring
them. You know it’s not like you’re alone in the
world.
Within Self-management of Distress participants
described learning a range of new coping skills for man-
aging feelings of distress and physical symptoms as well
as ways to manage family relationships, and come to a
sense of acceptance about their illness. New coping skills
included relaxation, problem solving and managing
thoughts that helped them to manage their distress. For
example:
I found when she was doing the relaxation, the medi-
tation and explaining all that to me, I found all of that
really beneficial. And as I said after each session I
really felt uplifted. I really felt ok we can, I can, step
forward. I can move forward and deal with what’s
coming at me, or being thrown at me.
Just again that bit of moral support, a bit of practical
suggestions on how to problem solve, and how to stop
my brain running off at a million miles an hour.
That’s the thing, my brain just will not stop.
As well, skills for managing symptoms such as insomnia
and breathlessness were acquired with physical and
emotional well-being often described as connected. For
example:
Well, especially on the breathing she (the therapist)
told me what to do and she even sent me some letters
to explain, you know the way I gotta do the breathing,
and the way when I get depressed like to relax.
Mainly relaxation and sort of talking things through,
I’ve been having trouble sleeping. But that did sort of
ease me with you know with my sleeping.
Cause there are things that happen from time to time
that you don’t know are related to the cancer and
that’s when you panic a little bit you know. Like I had
a symptom the other day that I ended up having to go
to the doctor and which I read was a side effect of the
treatment. But you immediately think ‘oh dear’, this
could be something more serious, you know. . . . I’ve
learnt to sort of not be so, to procrastinate about
things and you know, not let things go and don’t
self-diagnose.
Managing family relationships was also a described
benefit, as below:
The psychologist, she was really good, because she
sort of told me [daughter’s name] point of view too.
That . . . she wasn’t really accepting that I was sick
and you know things like that. And she [psycholo-
gist] sent me some materials on that side of things.
That helped me a lot to look at my daughter’s point
of view a bit more than what I had. So I thought that
was good. And it is really, really good just to have
somebody neutral to speak about those sorts of
things.
Participants also described acceptance and feeling better
able to face death. For example:
I was a bit worried about the last week of my you
know, dying, and she talked that over with me and
sent me out little booklets on that . . . I started to look
forward to her phone calls, well there you go, it was
someone nice to talk to who you could discuss and
who knew how you feel.
Stigma
Although in the interviews participants were not probed
directly about stigma-related issues, stigma emerged as a
superordinate theme with themes apparent about negative
emotion (e.g. guilt and hate); being aware of the smoking
and lung cancer connection; and the low public profile of
lung cancer compared with other cancers. Example quotes
are listed below:
I have to be aware to relax and to slow down and not get
uptight about issues or things. I find another thing is I
need to have a goal or plan my day ahead at least or a
few days ahead of what to do otherwise I feel a sense of
guilt.
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She gave me some ideas on how to cope with the
affliction [lung cancer] and my hatred. I was feeling a
bit of hate.
Even though I have got quite a few people that I can
talk to about it, but being lung cancer . . . um she told
me that people shun people who’ve got, you know,
lung cancer. And she said ‘Were you ashamed?’ and I
said ‘no’. I enjoyed it when I was smoking. . . . I don’t
know how to explain it. It really satisfied me to talk
like that, you know, to somebody. . . . Open, like
really really open. Yes and somebody that understood.
It’s just in my opinion, um I have had lung cancer. I’ve
had a tumour taken out. I never went through chemo
or all that. But I feel um . . . no there was not a lot of
input talking about lung cancer . . . When you hear
they’re all having relays for this, relays for breast
cancer, prostate cancer, all the other cancers, and you
know, lung cancer there’s nothing. They don’t have
any fundraising for lung cancers and things like that.
Barriers to intervention
A superordinate theme of Avoidance was identified with
participants describing not wanting to discuss the cancer;
already having adequate support; and being unwilling to
change. For example:
I just have a bit of a problem with sort of getting my
head around the value of the whole thing. Maybe I
have got the wrong attitude or whatever but I have
just tried to handle this lung cancer the best way I can
. . . Well to be quite honest I’m not a very good con-
versationalist. I’m a very private person and don’t sort
of talk about things much. I don’t want to insult you
or anything but as I say I’m not a great one at talking
about, um, you know sort of the set up with the
business with the cancer etcetera. You know it’s just
something I felt that I had to deal with as best I could.
Cause I’ve got great family support. Look, I’ve got a
friend that’s going through cancer at the moment, I’m
talking with her and I’ve got a friend who survived
lung cancer and I talk to her when I wanna talk to
someone that’s been there.
I haven’t changed for 43 years, now why should I
change now? I’m not going to change.
Reasons why participants did not access intervention
Nine participants who did not commence the interven-
tion sessions took part in semi-structured interviews with
reasons for not commencing including not wanting to
discuss the cancer; no need or already having support; and
practical issues. Example quotes are listed below:
I just didn’t really want to talk about it that much.
I told her I really didn’t think I needed her. I would
only be wasting my time because I’ve got no qualms.
Well I couldn’t see the point in it. . . . You know
it’s just another step in life, and I’ve never worried
about it.
I have trouble on the phone, I have dreadful trouble
with the mobile. Just mainly because of the compli-
cations with the hearing.
DISCUSSION
The present study describes the first report, to our knowl-
edge, of a cognitive behavioural intervention applying
acceptance-focused strategies to reduce psychological
distress in patients with lung cancer and ameliorate the
negative effects of health-related stigma in this vulnerable
patient group. Importantly, the intervention was tel-
ephone delivered in order to reduce barriers to access from
physical illness and geographic location. For those partici-
pants who completed final assessments the intervention
was accompanied by improvements in psychological out-
comes, particularly with regards to depression where large
effect sizes were observed. Health-related stigma was also
reduced, with shame and stigma about having lung cancer
most affected. These improvements occurred in the face of
a declining quality of life, and suggest that well targeted
psychological care with an acceptance focus may be of
value for lung cancer patients.
Qualitative feedback about the intervention also vali-
dated the intervention approach. Specifically, patients very
eloquently described how learning skills such as problem
solving, goal setting, challenging unhelpful thoughts and
learning to relax, combined with an empathic therapeutic
relationship, improved their ability to cope with their
illness. The cognitive behavioural approach applied in this
study was linked to practical advice about relieving symp-
toms such as breathlessness and insomnia, and this
appeared well matched to the demand characteristics of
lung cancer where symptom distress and psychological
adjustment are strongly linked (Tishelman et al. 2005; Lin
et al. 2013). Overall, the therapeutic relationship emerged
as a crucial and central component of the intervention that
allowed the safe discussion of fears and concerns about the
self, and the stigmatised self, as well as fears about death
and the future; and for these issues to be at least in part
resolved. In this regard, the therapeutic relationship is a
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central part of acceptance-based approaches, where it
is used as a metaphor for how participants might adjust
their relationship with themselves to be more gentle, non-
judgemental and accepting.
Other researchers have noted that at present there are no
stigma reduction interventions available for lung cancer
patients, and proposed that education about the cancer and
its treatment, support groups, and advocacy may be helpful
(Brown Johnson et al. 2013). Others have proposed that
cognitive behavioural interventions approaches that incor-
porated self-forgiveness and acceptance may be appropriate
(Hamann et al. 2014). In this regard, a recent pilot study
of Acceptance Commitment Therapy with 45 patients
with mixed cancer types (mostly breast cancer) reported
improvements in quality of life, distress and mood at
3-month follow-up with medium to large effect sizes (Feros
et al. 2013). These authors suggested that psychological
flexibility leading to acceptance of distress appears to be
the mechanism of benefit. Our research provides the first
proof of concept for applying acceptance approaches to
stigma not only in lung cancer, but to cancer more broadly.
In this study we also validate a telephone support
approach is acceptable to this patient group and this has
important implications for translation in the field and
for broad population access. Specifically, a face to face
approach that centralises service delivery will likely disad-
vantage people who do not live near tertiary treatment
centres or who are too unwell to travel. As in previous lung
cancer patient research (Schofield et al. 2013), we did expe-
rience high levels of attrition over the course of the project,
due most often to a deterioration of the patients’ physical
condition. Participants who did not commence the
intervention had poorer quality of life and hence may have
felt too unwell to participate, a conclusion again supported
by the qualitative data. From the qualitative inter-
views we elicited from some participants a stated unwill-
ingness to even discuss their cancer. As well, they were
heavier smokers, and we speculate that in the context of
continued smoking after a lung cancer diagnosis, patients
may feel more stigmatised by their cancer and this may be
a block to not only seeking, but also accepting support.
These findings reinforce the challenges of providing psy-
chosocial support to a very unwell patient population,
challenges that are magnified in the context of health-
related stigma.
The present study comprised a small convenience
sample from which generalisations cannot be drawn.
However as a first step in the testing of a complex inter-
vention a preliminary study phase to assess feasibility is
crucial (Craig et al. 2006). The theoretical basis of the
intervention was based on a comprehensive literature
review from which the suitability of a cognitive behav-
ioural approach to address stigma was confirmed
(Chambers et al. 2012). Further, we were able to build the
intervention upon a generic intervention approach that we
have found highly acceptable in both the research and
practice setting (Chambers et al. 2014). The testing of this
Psychological Wellness intervention in a large-scale
randomised controlled trial is the next logical step to
determine if this intervention is effective in reducing the
psychological distress and stigma that is associated with
lung cancer.
In conclusion, health-related stigma is part of the lung
cancer experience that to date has been neglected in the
tobacco control and lung cancer control narrative. If one
can envision being diagnosed with a life-threatening
illness and facing daily reminders in the form of health
warnings about the likely fatal outcome of the disease and
assigning personal responsibility for the illness, that
stigma results is not surprising. What is now needed is a
research and practice response to fully address the psycho-
logical needs of these patients and their families. This
study is a further step towards such a response.
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